LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Kentucky KY
Legislatures
2022 Regular Session
House
Bills
HB98
KY
Kentucky House Bill HB98
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Kentucky 2022 Regular Session
Kentucky House Bill HB98
Introduced
1/4/22
Refer
1/4/22
Caption
AN ACT relating to coverage for hepatitis C virus infection testing and treatment in pregnant women.
Latest HB98 Activity
Companion Bills
No companion bills found.
Previously Filed As
KY HB322
AN ACT relating to coverage for hepatitis C virus infection.
KY HB299
AN ACT relating to coverage for hepatitis C virus infection.
KY HB709
AN ACT relating to mental health coverage in connection with pregnancy.
KY HB633
AN ACT relating to mental health coverage in connection with pregnancy.
KY HB284
AN ACT relating to mental health coverage in connection with pregnancy.
KY HB413
AN ACT relating to mental health coverage in connection with pregnancy.
KY SB111
AN ACT relating to coverage for the treatment of stuttering.
KY HB540
AN ACT relating to coverage for COVID-19 testing.
KY HB412
AN ACT relating to coverage for the treatment of postpartum mood disorders.
KY HB683
AN ACT relating to coverage for the treatment of postpartum mood disorders.
Similar Bills
KY HB412
AN ACT relating to coverage for the treatment of postpartum mood disorders.
KY HB68
AN ACT relating to coverage for injectable epinephrine devices.
KY HB183
AN ACT relating to coverage for injectable epinephrine devices.
KY HB709
AN ACT relating to mental health coverage in connection with pregnancy.
KY HB55
AN ACT relating to coverage of mental health wellness examinations.
KY HB768
AN ACT relating to coverage for cranial conditions.
KY HB443
AN ACT relating to coverage for parental and guardian depression screenings.
KY HB556
AN ACT relating to coverage for injectable epinephrine devices.